October 31, 2020
Rose
Gilead Sciences said Wednesday that remdesivir, which has been authorized for emergency use since the spring, brought in $873 million in revenues so far this year.
from Health https://ift.tt/31QSZsg
October 31, 2020
Rose
Health, Health - The New York Times
No comments
Related Posts:
The Impact of Early Sexual Initiation on Boys- Generic Drugmakers Conspired to Inflate Prices Up to 1,000%, State Prosecutors Say
- A Little-Known Skin Disease That Can Disrupt People’s Sex Lives
- The Potentially Lifesaving Difference in How a Gun Is Stored
- Your 5G Phone Won’t Hurt You. But Russia Wants You to Think Otherwise.
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment